ELACESTRANT for Hormone receptor positive her2 negative breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where ELACESTRANT was used for Hormone receptor positive her2 negative breast cancer.
Most Reported Side Effects for ELACESTRANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 1,454 | 21.0% | 22 | 137 |
| Fatigue | 1,081 | 15.6% | 13 | 101 |
| Disease progression | 777 | 11.2% | 9 | 45 |
| Vomiting | 662 | 9.6% | 21 | 101 |
| Diarrhoea | 540 | 7.8% | 7 | 56 |
| Death | 499 | 7.2% | 499 | 66 |
| Drug ineffective | 478 | 6.9% | 4 | 40 |
| Constipation | 389 | 5.6% | 5 | 42 |
| Product dose omission issue | 364 | 5.3% | 9 | 102 |
| Decreased appetite | 363 | 5.2% | 8 | 51 |
| Pain | 361 | 5.2% | 7 | 49 |
| Arthralgia | 325 | 4.7% | 3 | 16 |
| Asthenia | 239 | 3.5% | 9 | 50 |
| Abdominal discomfort | 230 | 3.3% | 3 | 27 |
| Dyspepsia | 230 | 3.3% | 2 | 22 |
Other Indications for ELACESTRANT
Product used for unknown indication (6,377)
Breast cancer female (261)
Breast cancer metastatic (226)
Breast cancer (57)
Neoplasm malignant (12)
Metastases to bone (5)
Other Drugs Used for Hormone receptor positive her2 negative breast cancer
RIBOCICLIB (2,343)
LETROZOLE (1,106)
FULVESTRANT (823)
PALBOCICLIB (386)
ABEMACICLIB (220)
ANASTROZOLE (187)
ALPELISIB (171)
PACLITAXEL (92)
EXEMESTANE (86)
CYCLOPHOSPHAMIDE (83)